882050-17-1

Basic information

• Product Name: 5-O-(4-azido-4,6-dideoxy-β-D-glucopyranosyl)-1-N-[(S)-4-(benzyloxycarbonyl-amino)-2-hydroxybutanoyl]-3,2',6'-triazido-3',4'-dideoxy-3'-enoneamine
• Synonyms: 5-O-(4-azido-4,6-dideoxy-β-D-glucopyranosyl)-1-N-[(S)-4-(benzyloxycarbonyl-amino)-2-hydroxybutanoyl]-3,2',6'-triazido-3',4'-dideoxy-3'-enoneamine
• CAS NO: 882050-17-1
• Molecular Weight: 772.735
• Mol File: 882050-17-1.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 5-O-(4-azido-4,6-dideoxy-β-D-glucopyranosyl)-1-N-[(S)-4-(benzyloxycarbonyl-amino)-2-hydroxybutanoyl]-3,2',6'-triazido-3',4'-dideoxy-3'-enoneamine(CAS DataBase Reference)
• NIST Chemistry Reference: 5-O-(4-azido-4,6-dideoxy-β-D-glucopyranosyl)-1-N-[(S)-4-(benzyloxycarbonyl-amino)-2-hydroxybutanoyl]-3,2',6'-triazido-3',4'-dideoxy-3'-enoneamine(882050-17-1)
• EPA Substance Registry System: 5-O-(4-azido-4,6-dideoxy-β-D-glucopyranosyl)-1-N-[(S)-4-(benzyloxycarbonyl-amino)-2-hydroxybutanoyl]-3,2',6'-triazido-3',4'-dideoxy-3'-enoneamine(882050-17-1)

Safety Data

• Hazardous Substances Data: 882050-17-1(Hazardous Substances Data)

Upstream product

• 40371-50-4 S-4-benzyloxycarbonylamino-2-hydroxybutyric acid 
• 860640-70-6 1,3,2',6'-tetraazido-3',4'-dideoxy-3'-enoneamine 
• 882050-14-8 1-N-tet-butoxycarbonyl-3,2',6'-triazido-3',4'-dideoxy-3'-enoneamine 
• 882050-15-9 6-O-benzoyl-1-N-tet-butoxycarbonyl-3,2',6'-triazido-3',4'-dideoxy-3'-enoneamine 
• 882050-12-6 5,6-di-O-(4-chlorobenzoyl)-1,3,2',6'-tetraazido-3',4'-dideoxy-3'-enoneamine 
• 882050-13-7 5,6-di-O-(4-chlorobenzoyl)-1-N-tet-butoxycarbonyl-3,2',6'-triazido-3',4'-dideoxy-3'-enoneamine 
• 882050-19-3 Benzoic acid (1S,2S,3R,4S,6R)-4-azido-3-((2R,3R,6S)-3-azido-6-azidomethyl-3,6-dihydro-2H-pyran-2-yloxy)-6-tert-butoxycarbonylamino-2-((2S,3R,4S,5R,6R)-3,4-diacetoxy-5-azido-6-methyl-tetrahydro-pyran-2-yloxy)-cyclohexyl ester 
• 882050-16-0 5-O-(4-azido-4,6-dideoxy-β-D-glucopyranosyl)-1-N-tert-butoxycatbonyl-3,2',6'-triazido-3',4'-dideoxy-3'-enoneamine 

Relevant articles and documents

Novel anti bacterial compounds

The invention relates to novel paranmycin compounds that have activity against gram positive and gram negative bacteria, preferably bacteria that are resistant to other antibiotics. Paranmycins are of the general formula